Opinion · 4 Dec 2023
Conference abstractPublished 2023
The Difficult Child with Difficult Nephrotic Syndrome
Fortis Hospital, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Nephrotic syndrome is one of the commonest renal disorders ssn in children. We have also evaluated newer therapeutic alternatives in children with nephrotic syndrome. Majority of the children have relapses. In a randomized control trial we compared abrupt stoppage of prednisone with slow tapering over 2 months and found that the tapering protocol was associated with a much lower relapse rate. In another controlled trial, we found that intravenous cyclophosphamide is a useful and cost effective alternative, in maintaining remission in children, who are frequent relapser and steroid dependant as compared to oral cyclophosphamide and that too at a lesser cumulative dose with much lesser side-effects. The treatment of steroid resistant (SR) idiopathic focal segmental glomerulosclerosis (FSGS) continues to pose a therapeutic challenge. Although cyclosporine is one of the alternatives available for these children it is an expensive medication besides having the disadvantage of its inherent nephrotoxicity. We evaluated the efficacy of intravenous pulse cyclophosphamide therapy in children with steroid resistant FSGS. These children who are not only prone to develop chronic renal failure but also have a risk of recurrence of disease in the post transplant period. We observed that monthly intravenous pulse cyclophosphamide infusions are a safe, effective and economical therapeutic modality in steroid resistant children with idiopathic FSGS. In an another study, we evaluated the role of histopathology in the management of steroid resistant nephrotic in children. We found that children with SRNS secondary to MCD, are more likely to achieve remission as compared to non- MCD subtypes and have a better long-term prognosis. Hence kidney biopsy is of significant prognostic value in SRNS. We were amongst the first groups to evaluate the role of Tacrolimus in steroid resistant Nephrotic syndrome. Our results suggest that TAC is an effective therapeutic modality for SRNS, including the subgroup of children nonresponsive to the current therapeutic modalities like cyclophosphamide and cyclosporine.
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Nephrology & Renal Diseases.
Opinion · 4 Dec 2023
Unveiling Diuretics: A Comprehensive Exploration of a Vital Drug Class
Perspective · 4 Dec 2023
The Silent and Progressive Threat of Hypertensive Nephropathy: Risk Factors and Treatment Options
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Renal Diseases
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Sanjeev Gulati”

